GoodRx Holdings, Inc. (GDRX) Operating Margin
- Operating margin · 12 months: Value 9.54%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.54% | Operating income / revenue. Period ending 2026-06-30. $74.94M ÷ $785.23M × 100 ≈ 9.54% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 74.94M USD | Operating Income (Loss) |
| Revenue | 785.23M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 116.84M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74.94M | $785.23M | (m) | $116.84M | (m) | 9.54% |
| 2026-03-31 | $78.12M | $787.89M | (m) | $120.06M | (m) | 9.92% |
| 2025-12-31 | $87.49M | $796.85M | (m) | $121.03M | (m) | 10.98% |
| 2025-09-30 | $82.99M | $800.65M | (m) | $123.83M | (m) | 10.37% |
| 2025-06-30 | $88.78M | $799.87M | (m) | $122.95M | (m) | 11.10% |
| 2025-03-31 | $81.84M | $797.41M | (m) | $123.87M | (m) | 10.26% |
| 2024-12-31 | $65.85M | $792.32M | (m) | $123.75M | (m) | 8.31% |
| 2024-09-30 | $29.38M | $790.38M | (m) | $124.04M | (m) | 3.72% |
| 2024-06-30 | $-29.36M | $775.09M | (m) | $133.51M | (m) | -3.79% |
| 2024-03-31 | $-30.93M | $764.16M | (m) | $133.94M | (m) | -4.05% |
| 2023-12-31 | $-27.01M | $750.26M | (m) | $135.84M | (m) | -3.60% |
| 2023-09-30 | $-6.98M | $737.73M | (m) | $140.57M | (m) | -0.95% |
| 2023-06-30 | $15.63M | $745.09M | (m) | $136.88M | (m) | 2.10% |
| 2023-03-31 | $-6.72M | $747.21M | (m) | $141.00M | (m) | -0.90% |
| 2022-12-31 | $1.74M | $766.55M | (m) | $143.14M | (m) | 0.23% |
| 2022-09-30 | $11.76M | $795.70M | (m) | $141.43M | (m) | 1.48% |
| 2022-06-30 | $34.47M | $803.49M | (m) | $140.58M | (m) | 4.29% |
| 2022-03-31 | $38.16M | $788.32M | (m) | $134.74M | (m) | 4.84% |
| 2021-12-31 | $13.41M | $745.42M | (m) | $125.86M | (m) | 1.80% |
| 2021-09-30 | $-297.79M | $685.71M | (m) | $114.48M | (m) | -43.43% |
| 2021-06-30 | $-366.47M | $631.06M | (m) | $95.26M | (m) | -58.07% |
| 2021-03-31 | $-324.39M | $577.72M | (m) | $77.65M | (m) | -56.15% |
| 2020-12-31 | $-275.72M | $550.70M | (m) | $61.82M | (m) | -50.07% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $139.68M | $388.22M | (m) | $29.30M | (m) | 35.98% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $77.25M | $249.52M | (m) | $43.89M | (m) | 30.96% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.